HighlightsThe planned 50,000 metre Phase 2 drill program is advancing rapidly and ahead of schedule, with 27,300 metres ...

Octave Bioscience, Inc., a commercial-stage precision neurology company pioneering a new standard for managing multiple sclerosis (MS) and other neurodegenerative diseases such as Parkinson’s disease, ...

The demise of the two programmes still leaves Roche with one Huntington's candidate, the gene therapy RG6662, which is in a ...

Facing pressure to speed up AI deployment while also showing ROI on AI spend, many leaders are downplaying the need to ...

The death of a fetus after 28 weeks of pregnancy but before delivery is known as stillbirth, and it continues to be a major ...

As heavy monsoon rains disrupt life across several parts of India, stories have emerged of employees struggling to convince their employers to allow them to work from home. In some cases, workers have ...

The University of Seoul kicked off its 2026 overseas study tour program on Wednesday, sending 100 students in 25 teams to 12 ...

A small trial finds that the technique helps some of the condition's brain symptoms.

The Nigerian Communications Commission and relevant stakeholders have commenced moves to end the repeated excavation of roads ...

The young adults of Generation Z are embracing their faith as they search for answers and a sense of community in an anxious ...

A comprehensive analysis of 19 obesity drugs reveals no single standout, with weight loss often accompanied by muscle loss and side effects.

Conexeu Completes 12-Month Preclinical P.R.O.O.F Study, Supporting Its Intended Move Into the $11 Billion Medical Aesthetics Market as a Platform¹ ...